Get started
Live feed
PRReleasevia Quantisnow
Fulcrum Therapeutics Inc. logo

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Historical context for FULC

Across the 19 sessions after earlier FULC headlines, the stock closed higher 8 times and lower 11 times, with a median move of 4.2% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

FULC close-to-close change in the session after earlier headlines
SessionEarlier headlineFULCSPY
Apr 27, 2026Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for First Quarter 2026and 1 other headline that session-1.5%+0.2%
Apr 20, 2026Fulcrum Therapeutics to Host First Quarter 2026 Financial Results Conference Call and Webcast on Monday, April 27, 2026, at 8:00 a.m. ET-4.2%-0.2%
Mar 19, 2026MedicAlert Foundation, Sickle Cell Disease Association of America, Inc. (SCDAA), and Fulcrum Therapeutics Partner to Accelerate Emergency Department Access to Critical Care Information for People Living with Sickle Cell Disease+1.7%-0.2%
Mar 9, 2026Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)-2.8%+0.9%
Mar 3, 2026Fulcrum Therapeutics to Participate in the Leerink Partners Global Healthcare Conference+0.8%-0.9%
Feb 24, 2026Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2025and 1 other headline that session-21.2%+0.7%
Quantisnow market dataNASDAQ
Fulcrum Therapeutics Inc. logo
FULC
Fulcrum Therapeutics Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2019
Get push alerts for FULC

Follow FULC and get a push notification the moment its next story breaks.

Full FULC profile on Quantisnow

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FULC (Fulcrum Therapeutics Inc.) and more on Quantisnow.